On Monday, Shares of Eleven Biotherapeutics Inc (NASDAQ:EBIO), added 11.45% and closed at $2.92 in the last trading session. The last trading range of the stock ranges between $2.82 and $3.23. The company’s Market capitalization is $55.50 million with the total Outstanding Shares of 20.17 million. During the 52-week trading session the minimum price at which share price traded, registered at $0.25 and reached to max level of $5.97. The EPS of company is strolling at -1.97. Eleven Biotherapeutics, Inc. (EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based on its Targeting Protein Therapeutics (TPTs) platform, recently stated financial results for the third quarter ended September 30, 2016, and recent business highlights.
“This is an exciting period for Eleven. We accomplished the Roche licensing deal, counting $30 million in upfront and milestone payments received to date. We also accomplished the acquisition of Viventia Bio Inc. which allowed us to become a late-stage oncology company. Perhaps most excitingly, we are making noteworthyprogress in moving forward what we believe could be therapeutics that materially improve patients’ lives. We anticipate complete enrollment in the first half of next year for our Phase 3 clinical trial of Vicinium™ as a potential treatment for high-grade non-muscle invasive bladder cancer, and expect topline data in the first half of 2018,” said Stephen Hurly, President and Chief Executive Officer of Eleven Biotherapeutics. “We also plan to initiate our Phase 2 trial in late-stage squamous cell carcinoma of the head and neck with Proxinium in combination with a checkpoint inhibitor in the first half of 2017. Also in 2017, we plan on submitting an IND with the FDA for our lead product in our systemic pipeline based on our proprietary payload deBouganin. With the combined expertise of Eleven and the Viventia team, I am very excited about the opportunities we have ahead.”
Shares of Applied Materials, Inc. (NASDAQ:AMAT), jumped 0.59% and closed at $28.99 in the last trading session. The last trading range of the stock ranges between $28.93 and $29.50. The company’s Market capitalization is $32.05 Billion with the total Outstanding Shares of 1.08 billion. During the 52-week trading session the minimum price at which share price traded, registered at $15.44 and reached to max level of $31.07. The EPS of company is strolling at1.28. Applied Materials, Inc. will hold a webcast to discuss its fourth quarter and fiscal 2016 financial results, together with its business outlook, on Thursday, November 17, 2016 at 4:30 p.m. ET (1:30 p.m. PT).